NICD levels and Notch target genes, including Hey1, Hes1, and cyclin D1 (Ccnd1), were significantly upregulated in HG-treated Met1 cancer cells (Fig. 3a, b), suggesting that HG activates Notch signaling. The gene discussed is HEY1; the disease is cancer.